ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

MYMD MyMD Pharmaceuticals Inc

2.69
-0.04 (-1.47%)
Última actualización: 10:42:30
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MyMD Pharmaceuticals Inc MYMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.04 -1.47% 2.69 10:42:30
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.69 2.69 2.72 2.73
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/3/202415:30EDGAR2Form 8-K - Current report
05/3/202410:00EDGAR2Form 8-K - Current report
05/3/202408:15BWMyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum..
14/2/202414:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202410:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:57EDGAR2Form 8-K - Current report
13/2/202410:45BWMyMD Pharmaceuticals Announces Reverse Stock Split to..
06/12/202308:15EDGAR2Form 8-K - Current report
06/12/202308:15BWMyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical..
19/10/202308:00EDGAR2Form 8-K - Current report
19/10/202308:00BWMyMD Announces Preclinical Study Results Showing Novel..
13/10/202316:00EDGAR2Form 8-K - Current report
04/10/202315:30EDGAR2Form 8-K - Current report
04/10/202306:30BWMyMD Pharmaceuticals to Present Updated Statistically..
08/9/202316:24EDGAR2Form 8-K - Current report
24/8/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:30EDGAR2Form 8-K - Current report
14/8/202307:30BWFDA Accepts MyMD Pharmaceuticals’ Investigational New Drug..
03/8/202315:30EDGAR2Form 8-K - Current report
02/8/202307:30BWMyMD Pharmaceuticals to Hold Conference Call Today to..
01/8/202315:30EDGAR2Form 8-K - Current report
31/7/202308:00EDGAR2Form 8-K - Current report
31/7/202308:00BWMyMD Pharmaceuticals Reports Statistically Significant..
21/7/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/7/202307:30EDGAR2Form 8-K - Current report
30/6/202315:30EDGAR2Form ARS - Annual Report to Security Holders
30/6/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements

Su Consulta Reciente

Delayed Upgrade Clock